Diagnosis and Clinical Management in Hematologic Oncology

Dear Colleagues,

Hematologic malignancies encompass a broad spectrum of disorders, including lymphomas, multiple myeloma, chronic myeloproliferative neoplasms, and acute and chronic leukemias, among others. These diseases continue to represent a major clinical challenge due to their biological diversity, variable prognosis, and evolving therapeutic landscape. In recent years, advances in molecular diagnostics, next-generation sequencing, and functional imaging have significantly improved our ability to characterize these conditions, enabling more precise risk stratification and personalized therapeutic approaches.

At the same time, the rapid development of novel agents—such as targeted therapies, monoclonal antibodies, and cellular immunotherapies—is reshaping the standard of care. However, integrating these innovations into clinical practice requires a careful balance between efficacy, safety, and accessibility.

This Special Issue brings together original research and reviews that highlight progress in diagnostic strategies, prognostic markers, and clinical management across the spectrum of hematologic malignancies, aiming to provide clinicians and researchers with insights that can translate into improved patient outcomes.

Dr. Sunil Lakhwani
Dr. José María Raya-Sánchez
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.